Laryngeal squamous cell cancer (SCC) TNM
Primary Tumour (T)
Supraglottis
T1 Tumour limited to one subsite of supraglottis with normal vocal cord mobility
T2 Tumour invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of piriform sinus) without fixation of the larynx
T3 Tumour limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, pre-epiglottic space, paraglottic space, and/or inner cortex of thyroid cartilage
T4a Tumour invades through the thyroid cartilage and/or invades tissues beyond the larynx, e.g., trachea, soft tissues of neck including deep/extrinsic muscle of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), strap muscles, thyroid, oesophagus
T4b Tumour invades prevertebral space, encases carotid artery, or mediastinal structures
Glottis
T1 Tumour limited to vocal cord(s) (may involve anterior or posterior commissure) with normal mobility
T1a Tumour limited to one vocal cord
T1b Tumour involves both vocal cords
T2 Tumour extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility
T3 Tumour limited to larynx with vocal cord fixation and/or invades paraglottic space, and/or inner cortex of the thyroid cartilage
T4a Tumour invades through the outer cortex of the thyroid cartilage, and/or invades tissues beyond the larynx, e.g., trachea, soft tissues of neck including deep/extrinsic muscle of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), strap muscles, thyroid, oesophagus
T4b Tumour invades prevertebral space, encases carotid artery, or mediastinal structures
Subglottis
T1 Tumour limited to subglottis
T2 Tumour extends to vocal cord(s) with normal or impaired mobility
T3 Tumour limited to larynx with vocal cord fixation
T4a Tumour invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx, e.g., trachea, soft tissues of neck including deep/extrinsic muscles of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), strap muscles, thyroid, oesophagus
T4b Tumour invades prevertebral space, encases carotid artery, or mediastinal structures
Regional Lymph Nodes (N)
Nx Regional lymph nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Metastasis in a single ipsilateral lymph node, ≤3 cm and no extranodal extension (ENE)
N2a Metastasis in a single ipsilateral lymph node, >3cm but ≤6cm, no ENE
N2b Metastasis in multiple ipsilateral lymph nodes, all ≤6cm and no ENE
N2c Metastasis in bilateral or contralateral lymph nodes, ≤6cm and no ENE
N3a Metastasis in any lymph node >6cm with no ENE
N3b Metastasis in any lymph node(s) with clinical ENE *
Notes: * The presence of skin involvement or soft tissue invasion with deep fixation/tethering to underlying muscle or adjacent structures or clinical signs of nerve involvement is classified as clinical extranodal extension. Midline nodes are considered ipsilateral nodes.
Distant Metastasis (M)
M0 No distant metastasis
M1 Distant metastasis
pTNM Pathological Classification of Malignant Tumours (8th Edition, UICC, 2018)
Primary Tumour (T)
Supraglottis
pTx Primary tumour cannot be assessed
pT0 No evidence of primary tumours
pTis Carcinoma in situ
pT1 Tumour limited to one subsite of supraglottis with normal vocal cord mobility
pT2 Tumour invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of piriform sinus) without fixation of the larynx
pT3 Tumour limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, pre-epiglottic space, paraglottic space, and/or inner cortex of thyroid cartilage
pT4a Tumour invades through the thyroid cartilage and/or invades tissues beyond the larynx, e.g., trachea, soft tissues of neck including deep/extrinsic muscle of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), strap muscles, thyroid, oesophagus
pT4b Tumour invades prevertebral space, encases carotid artery, or mediastinal structures
Glottis
pTx Primary tumour cannot be assessed
pT0 No evidence of primary tumours
pTis Carcinoma in situ
pT1 Tumour limited to vocal cord(s) (may involve anterior or posterior commissure) with normal mobility
pT1a Tumour limited to one vocal cord
pT1b Tumour involves both vocal cords
pT2 Tumour extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility
pT3 Tumour limited to larynx with vocal cord fixation and/or invades paraglottic space, and/or inner cortex of the thyroid cartilage
pT4a Tumour invades through the outer cortex of the thyroid cartilage, and/or invades tissues beyond the larynx, e.g., trachea, soft tissues of neck including deep/extrinsic muscle of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), strap muscles, thyroid, oesophagus
pT4b Tumour invades prevertebral space, encases carotid artery, or mediastinal structures
Subglottis
pTx Primary tumour cannot be assessed
pT0 No evidence of primary tumours
pTis Carcinoma in situ
pT1 Tumour limited to subglottis
pT2 Tumour extends to vocal cord(s) with normal or impaired mobility
pT3 Tumour limited to larynx with vocal cord fixation
pT4a Tumour invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx, e.g., trachea, soft tissues of neck including deep/extrinsic muscles of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), strap muscles, thyroid, oesophagus
pT4b Tumour invades prevertebral space, encases carotid artery, or mediastinal structures
Pathological classification of Regional Lymph Nodes (pN)
Histological examination of a selective neck dissection specimen will ordinarily include 10 or more lymph nodes. Histological examination of a radical or modified radical neck dissection specimen will ordinarily include 15 or more lymph nodes.
pNx Regional lymph nodes cannot be assessed
pN0 No regional lymph node metastasis
pN1 Metastasis in a single ipsilateral lymph node, ≤3cm, no ENE
pN2a Metastasis in a single ipsilateral lymph node, ≤3cm With ENE+; OR single lymph node >3cm but ≤6cm and no ENE
pN2b Metastasis in multiple ipsilateral lymph nodes, ≤6cm, no ENE
pN2c Metastasis in bilateral or contralateral lymph nodes, ≤6cm, no ENE
pN3a Metastasis in any lymph node >6cm, no ENE
pN3b Metastasis in a single ipsilateral lymph node >3cm with ENE+; OR single contralateral node, any size with ENE+; OR multiple nodes, any size with ENE+
Note: Midline nodes are considered ipsilateral nodes.
Distant Metastasis (M)
pM1 Distant metastasis